• Wedbush Reiterates "Outperform" Rating for Spyre Therapeutics (NASDAQ:SYRE)

    Source: Buzz FX / 09 Nov 2024 22:16:18   America/New_York


    Wedbush Reiterates "Outperform" Rating for Spyre Therapeutics (NASDAQ:SYRE) Written by MarketBeat November 9, 2024 Share Link copied to clipboard. Spyre Therapeutics ( NASDAQ:SYRE - Get Free Report ) 's stock had its "outperform" rating res
    Read more...
Share on,